Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.

Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A (1990) 2.59

Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Proc Natl Acad Sci U S A (2011) 1.71

Prospects for cure in leukaemia. J Clin Pathol (1987) 1.07

Bone marrow transplantation. Part II--autologous. West J Med (1990) 0.90

Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas. Biol Blood Marrow Transplant (2010) 0.85

Survival of Mexican children with acute myeloid leukaemia who received early intensification chemotherapy and an autologous transplant. Biomed Res Int (2015) 0.79

Cancer therapy: reimbursement of new therapeutic technologies. Yale J Biol Med (1992) 0.78

Bone marrow transplantation as primary treatment of leukemia. West J Med (1987) 0.75

Acute leukemia: diagnosis, management, and potential for cure. Can Fam Physician (1988) 0.75

Allogeneic and autologous bone-marrow transplantation. Can Fam Physician (1988) 0.75

Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med (1991) 12.09

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06

Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72

Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother (1980) 4.53

Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A (1999) 3.91

Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med (1997) 3.44

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother (1993) 3.25

Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med (1981) 3.19

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood (2000) 2.82

Assessment of aldehyde dehydrogenase in viable cells. Blood (1995) 2.77

Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med (1979) 2.71

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med (1991) 2.59

Exploratory and confirmatory tests of the big five and Tellegen's three- and four-dimensional models. J Pers Soc Psychol (1994) 2.56

Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol (2001) 2.54

Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med (1986) 2.47

Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc (1967) 2.44

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol (1998) 2.39

A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol (2000) 2.37

Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood (2001) 2.35

Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood (1998) 2.31

Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer (1997) 2.30

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28

Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer (1990) 2.28

Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23

Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19

Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res (2000) 2.17

Ifosfamide: should the honeymoon be over? J Clin Oncol (1995) 2.13

Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (2001) 2.10

The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis (1980) 2.10

Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution. Arch Dermatol (1994) 2.05

The pediatrician and cancer prevention. Accepting the present, changing the future. Arch Pediatr Adolesc Med (1995) 1.98

Cytidine deaminase and the development of resistance to arabinosyl cytosine. Nat New Biol (1971) 1.97

Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90

Corynebacterium sepsis in oncology patients. Predisposing factors, diagnosis, and treatment. JAMA (1977) 1.90

Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90

Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood (1990) 1.88

Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res (1988) 1.86

Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties. J Immunol (1978) 1.85

Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med (1985) 1.84

Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol (1986) 1.82

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1987) 1.82

Semi-automated entry of clinical temporal-abstraction knowledge. J Am Med Inform Assoc (1999) 1.81

The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene (2006) 1.80

The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. Clin Immunol Immunopathol (1973) 1.78

Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood (1996) 1.76

Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75

Ophthalmic manifestations of leukemia. Arch Ophthalmol (1989) 1.75

Tool support for authoring eligibility criteria for cancer trials. Proc AMIA Symp (1999) 1.73

Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol (1995) 1.71

HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J Immunol (1981) 1.69

BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders. Blood (1996) 1.69

Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis (1983) 1.69

Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67

Cyclosporin A and the thymus. Immunopathology. Am J Pathol (1987) 1.65

Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med (1982) 1.64

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med (1986) 1.64

Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients. Cancer (1978) 1.63

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57

Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57

Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood (1998) 1.55

Septic reactions to platelet transfusions. A persistent problem. JAMA (1991) 1.55

Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion (1992) 1.54

The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51

The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51

Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood (2000) 1.51

Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene. Blood (2001) 1.50

Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50

Immunosuppressive drugs. Pharmacol Rev (1970) 1.48

Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. J Immunol (1982) 1.48

Leukemic retinopathy. Relationship between fundus lesions and hematologic parameters at diagnosis. Ophthalmology (1989) 1.46

Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10) Br J Haematol (1990) 1.45